This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Intravenous urography

Authoring team

Intravenous urography, or IVU, was previously one of the most commonly performed investigations in urology. Its primary use is to demonstrate the anatomy of the urinary tract.

An iodine-containing contrast medium is given by intravenous injection. Non-ionic media are preferred as they are less hazardous than the older, ionic media.

A series of abdominal radiographs are taken at the time of injection, at measured times afterwards, and after the patient has voided. As the contrast is excreted, the renal parenchyma, renal pelvis, ureters and bladder are outlined in order. The post-voiding film allows assessment of residual volume.

Delayed films may be required when upper tract obstruction or slow opacification of the collecting system is present. Films may be taken at 1, 2, 4, 8 or 16 hours etc. after the initial injection of contrast.

Frusemide may be given to assess clearance in cases of equivocal pelvi-ureteric junction obstruction.

A crude assessment of renal function is gained from the speed at which contrast is excreted.


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.